Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Shutterstock/Tibor Duris

Ireland plans to work with other countries to drive down the cost of expensive medicines

Ireland is to open negotiations with four countries on drug pricing and supply.

THE IRISH GOVERNMENT wants to work with other EU countries in a bid to drive down the cost of expensive medicines.

Minister for Health Simon Harris today announced that Ireland is to open negotiations with Belgium, the Netherlands, Luxembourg and Austria on drug pricing and supply.

Harris will now issue a letter of intent to his counterparts in those four countries formally signalling Ireland’s interest in joining the existing collaboration, known as the BeNeLuxA Initiative.

“I’m delighted that Cabinet has given formal approval for Ireland to open these negotiations and I look forward to working with these countries to explore opportunities to secure affordable access to new medicines for Irish patients, through information sharing and policy exchange.

“In fact I will be travelling to Belgium and the Netherlands in the coming weeks and hope to begin discussions with my Ministerial counterparts in both countries,” said the health minister.

In an interview with TheJournal.ie last year, the minister said he was “exploring options” with other EU countries to see if he can bring down the cost of drugs bought by the state.

As Ireland has a population of over four and a half million people and Europe with 400 million, he said there could be deals to be done.

Securing access to new and innovative medicines, in a manner that’s affordable and sustainable, is one of the minister’s key objectives, he said.

Harris said there is a challenge, not unique to Ireland, to drive down the price tags of some drugs.

“That is why over the past two years my Department has been engaging with other European countries in an effort to identify solutions to medicines pricing, sustainability and supply,” he said.

Harris said working collaboratively with the BeNeLuxA countries “is a concrete step forward”.

“It will allow Ireland to explore opportunities, in an increasingly challenging environment of high pricing of medicines by pharmaceutical companies, to secure sustainable and affordable access for patients to new and innovative medicines,” said Harris.

Even in the best-case Brexit scenario, the Irish economy will still take a hit – government report>

Poll: Have you been affected by the rental crisis?

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Author
Christina Finn
View 28 comments
Close
28 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel

     
    JournalTv
    News in 60 seconds